Trial Profile

Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2 Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 23 Apr 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs JNJ 63871860 (Primary)
Indications Escherichia coli infections; Urinary tract infections
Focus Adverse reactions; Pharmacodynamics
Sponsors Janssen Research & Development

Most Recent Events

21 Nov 2019 Status changed from active, no longer recruiting to completed.
26 Jul 2019 Planned End Date changed from 31 Aug 2020 to 8 Sep 2019.
11 Jun 2018 Results presented at the ASM Microbe 2018

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com